Par Pharmaceutical Pramipexole Dihydrochloride Extended Release Tablets, 0.375 mg recall — FDA D-1038-2016
Failed Impurities/Degradation Specifications: Par Pharmaceutical is recalling Pramipexole Dihydrochloride Extended Release tablets because it contains a known product impurity above…